4//SEC Filing
Heath-Chiozzi Margo 4
Accession 0001415889-24-015544
CIK 0000744218other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:06 PM ET
Size
12.9 KB
Accession
0001415889-24-015544
Insider Transaction Report
Form 4
Heath-Chiozzi Margo
SVP OF REGULATORY AFFAIRS
Transactions
- Exercise/Conversion
Incentive Stock Option (Right to Buy)
2024-06-03−58,369→ 23,023 totalExercise: $10.38Exp: 2030-06-18→ Common Stock (58,369 underlying) - Exercise/Conversion
Common Stock
2024-06-03$10.38/sh+58,369$605,870→ 71,752 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2024-06-03−6,289→ 0 totalExercise: $9.02Exp: 2028-06-13→ Common Stock (6,289 underlying) - Sale
Common Stock
2024-06-03$33.65/sh−58,369$1,964,088→ 13,383 total - Exercise/Conversion
Common Stock
2024-06-03$9.02/sh+6,289$56,705→ 13,383 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.27 to $34.08 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F2]As of June 13, 2022, the option is fully vested.
- [F3]25% vested on June 18, 2021 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001718112
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:06 PM ET
- Size
- 12.9 KB